Physician profile
Andrew C Roeser
NPI 1295972305
$660,387.13
in general payments reported to CMS, 2019-2025
14 companies · $339K in 2025
The $339K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $27K · 2021: $33K · 2022: $72K · 2023: $67K · 2024: $92K · 2025: $339K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $481K · Travel and Lodging: $7,916 · Consulting Fee: $6,549 · Food and Beverage: $2,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $480,556.02 |
| Travel and Lodging | $7,915.88 |
| Consulting Fee | $6,548.94 |
| Food and Beverage | $2,153.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $645,635.77 | 2019-2025 | Other - Miscellaneous, Invictus Mis, Battalion Tlif - Pc |
| Nuvasive, INC. | $11,540.79 | 2019-2023 | Pulse |
| Globus Medical, INC. | $1,866.33 | 2025 | Xlif, Modulus, Excelsius Gps |
| Abbott Laboratories | $546.36 | 2021-2025 | Eterna, Lamitrode Tripole |
| Nevro Corp. | $148.73 | 2022 | |
| Si-Bone, INC. | $121.94 | 2020 | |
| Zimmer Biomet Holdings, INC. | $114.27 | 2019 | |
| Medtronic USA, INC. | $108.16 | 2020 | |
| Biotissue Holdings INC. | $96.02 | 2024 | |
| Medtronic, INC. | $62.21 | 2021 | |
| Karl Storz Endoscopy-America | $61.46 | 2023 | |
| Ethicon US, LLC | $44.01 | 2020-2021 | |
| Depuy Synthes Sales INC. | $27.71 | 2020-2021 | |
| Biocomposites INC | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Roeser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.